ARTICLE | Clinical News
Arteria preclinical data
November 14, 2011 8:00 AM UTC
In mice and rats, oral AP-5258 significantly inhibited the transfer of postprandial triglycerides vs. an inactive control (p<0.01). Arteria plans to start a Phase I trial of the CD36 (GPIV) inhibitor...